Chongqing Zhifei Biological Products Co., Ltd. (SHE:300122)
12.61
-0.15 (-1.18%)
Sep 11, 2026, 3:04 PM CST
SHE:300122 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 2,105 | 2,626 | 2,706 | 6,341 | 2,622 | 4,308 |
Trading Asset Securities | - | - | 11.53 | - | - | - |
Cash & Short-Term Investments | 2,105 | 2,626 | 2,717 | 6,341 | 2,622 | 4,308 |
Cash Growth | -18.07% | -3.37% | -57.15% | 141.81% | -39.13% | 199.68% |
Accounts Receivable | 10,377 | 11,165 | 16,302 | 27,059 | 20,614 | 12,868 |
Other Receivables | 50.49 | 148.12 | 10.97 | 7.8 | 8.39 | 6.87 |
Receivables | 10,427 | 11,313 | 16,313 | 27,066 | 20,622 | 12,874 |
Inventory | 2,403 | 5,003 | 22,244 | 8,986 | 8,020 | 7,385 |
Prepaid Expenses | 1.46 | 0.14 | 4.91 | 9.73 | - | 0.59 |
Other Current Assets | 134.69 | 77.16 | 124.31 | 111.37 | 148.53 | 185.63 |
Total Current Assets | 15,071 | 19,019 | 41,403 | 42,514 | 31,413 | 24,754 |
Property, Plant & Equipment | 5,626 | 5,880 | 6,165 | 5,120 | 4,693 | 3,557 |
Long-Term Investments | 289.35 | 289.35 | 295 | 295 | 284.5 | 239 |
Goodwill | 19.28 | 19.28 | 19.28 | 19.28 | 19.28 | 19.28 |
Other Intangible Assets | 552.6 | 574.48 | 346.25 | 317.68 | 352.71 | 342.8 |
Long-Term Deferred Tax Assets | 3,892 | 3,697 | 966.88 | 569.19 | 186.08 | 115.34 |
Long-Term Deferred Charges | 2,221 | 2,090 | 1,871 | 1,088 | 731.97 | 485.04 |
Other Long-Term Assets | 147.23 | 150.07 | 231.11 | 308.42 | 322.5 | 534.91 |
Total Assets | 27,818 | 31,720 | 51,297 | 50,232 | 38,004 | 30,047 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Accounts Payable | 612.27 | 1,241 | 5,823 | 13,142 | 9,807 | 9,178 |
Accrued Expenses | 459.33 | 578.71 | 522.16 | 1,673 | 1,240 | 1,090 |
Short-Term Debt | 302.81 | 8,594 | 11,902 | 2,635 | 1,785 | 568.86 |
Current Portion of Long-Term Debt | 2,682 | 765.62 | 85.01 | 36.41 | - | - |
Current Portion of Leases | 9.53 | 9.2 | 11.77 | 10.2 | 9.81 | 0.25 |
Current Income Taxes Payable | - | 6.53 | 86.86 | 434.59 | 347.7 | 933.25 |
Current Unearned Revenue | 47.19 | 83.4 | 11.87 | 11.31 | - | - |
Other Current Liabilities | 950.64 | 1,125 | 418.82 | 143.86 | 40.17 | 99.62 |
Total Current Liabilities | 5,064 | 12,404 | 18,861 | 18,086 | 13,230 | 11,871 |
Long-Term Debt | 7,188 | 2,909 | 1,242 | 328.08 | 210.64 | 236.41 |
Long-Term Leases | 5.53 | 9.54 | 16.67 | 25.31 | 27.76 | 12.24 |
Long-Term Unearned Revenue | 244.04 | 256.05 | 281.68 | 228.27 | 238.34 | 222.2 |
Long-Term Deferred Tax Liabilities | 31.11 | 35.66 | 44.31 | 57.96 | 60.77 | 48.34 |
Total Liabilities | 12,532 | 15,614 | 20,446 | 18,726 | 13,768 | 12,390 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Common Stock | 2,394 | 2,394 | 2,394 | 2,400 | 1,600 | 1,600 |
Additional Paid-In Capital | 210.19 | 210.19 | 197.88 | 47.96 | 207.96 | 207.96 |
Retained Earnings | 12,427 | 13,236 | 28,262 | 29,058 | 22,428 | 15,849 |
Total Common Equity | 15,031 | 15,840 | 30,854 | 31,506 | 24,236 | 17,657 |
Minority Interest | 254.52 | 266.35 | -2.23 | - | - | - |
Shareholders' Equity | 15,286 | 16,106 | 30,851 | 31,506 | 24,236 | 17,657 |
Total Liabilities & Equity | 27,818 | 31,720 | 51,297 | 50,232 | 38,004 | 30,047 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Total Debt | 10,188 | 12,287 | 13,257 | 3,035 | 2,033 | 817.76 |
Net Cash (Debt) | -8,083 | -9,662 | -10,540 | 3,305 | 588.94 | 3,490 |
Net Cash Growth | - | - | - | 461.19% | -83.13% | - |
Net Cash Per Share | -3.38 | -4.04 | -4.40 | 1.38 | 0.25 | 1.45 |
Filing Date Shares Outstanding | 2,394 | 2,394 | 2,394 | 2,400 | 2,400 | 2,400 |
Total Common Shares Outstanding | 2,394 | 2,394 | 2,394 | 2,400 | 2,400 | 2,400 |
Working Capital | 10,007 | 6,615 | 22,542 | 24,428 | 18,183 | 12,883 |
Book Value Per Share | 6.28 | 6.62 | 12.89 | 13.13 | 10.10 | 7.36 |
Tangible Book Value | 14,459 | 15,246 | 30,488 | 31,169 | 23,864 | 17,295 |
Tangible Book Value Per Share | 6.04 | 6.37 | 12.74 | 12.99 | 9.94 | 7.21 |
Buildings | 2,919 | 2,880 | 2,840 | 2,522 | 1,705 | 1,042 |
Machinery | 3,642 | 3,605 | 3,396 | 2,526 | 2,064 | 1,369 |
Construction In Progress | 1,470 | 1,547 | 1,585 | 1,287 | 1,836 | 1,825 |